psychopharmacology-cme-horizontal

Pharmacokinetics of Aripiprazole: Clinical Summary

By Flavio Guzman, MD.

Formulations

  • Tablets
  • Orally disintegrating tablets
  • Liquid formulation
  • IM injection

General pharmacokinetics and drug interactions

Half-life

  • aripiprazole: 75 hours
  • dehydro-aripiprazole: 94 hours

Elimination
Mainly through hepatic metabolism involving two P450 enzymes:

  • CYP3A4: dose adjustment might be needed in the presence of inhibitors or inducers.
  • CYP2D6: dose adjustment might be needed in the presence of inhibitors.
Aripiprazole CYP3A4
Pharmacokinetics of aripiprazole: metabolism by cytochrome P450 3A4
Pharmacokinetics of aripiprazole: metabolism by cytochrome P450 2D6
Pharmacokinetics of aripiprazole: metabolism by cytochrome P450 2D6

Pharmacokinetics of oral administration

Absorption

  • Peak plasma concentrations occur within 3 to 5 hours.
  • Can be admininistered with or without food.
  • According to the manufacturer, a study found that plasma concentrations from the oral solution were higher than that from the tablet formulation.

Distribution

  • Volume of distribution in studies after IV administration is of 404 L or 4.9L/Kg (extense extravascular distribution)
  • Aripiprazole and dehydro-aripiprazole are greater than 99% bound to serum proteins (primarily albumin)

Pharmacokinetics of IM administration

  • Median times to the peak plasma concentration: 1 hours and 3 hours.
  • In one pharmacokinetic study [Boulton,2008], intramuscular aripiprazole demonstrated more rapid attainment of plasma aripiprazole concentrations than oral aripiprazole (78% and 5% of peak plasma concentration [Cmax] values at 0.5 hours postdose, respectively).

More Information on Aripiprazole

References

  1. Schatzberg, AF, Nemeroff, C . The American Psychiatric Publishing Textbook of Psychopharmacology. 4th ed.American Psychiatric Publishing, 2009.
  2. Otsuka America Pharmaceutical, Inc. Abilify (aripiprazole) prescribing information. Retrieved from http://www.abilify.com
  3. Boulton DW, Kollia G, Mallikaarjun S, Komoroski B, Sharma A, Kovalick LJ, et al. Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia. Clinical pharmacokinetics. 2008;47(7):475-85

PDF: LAI Antipsychotics

Screenshot_2017-01-07_12.39.54

Free PDF Download

  • New formulations (Aristada, Invega Trinza)
  • Practical dosing tables
Powered by ConvertKit

Free Course: “SSRIs: The Essentials”

Fluoxetine

Learn the essentials of SSRIs with our free online course.

One module per week:

  • The Mechanism of Action of SSRIs
  • Fluoxetine
  • Fluvoxamine
  • Paroxetine
  • Sertraline
  • Citalopram and Escitalopram

Download All Videos and Earn CME Credits

Icons-01Premium members have access to these benefits:

  • Instant access to more than 40 exclusive video tutorials
  • Downloads for offline access (audio, video and PPT files)
  • Mobile access
  • Monthly updates
  • Instant access to 9 CME credits
  • Up to 21 CME credits a year

Learn more about premium membership

PDF: LAI Antipsychotics

Screenshot_2017-01-07_12.39.54

Free PDF Download

  • New formulations (Aristada, Invega Trinza)
  • Practical dosing tables
Powered by ConvertKit